• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL CERTAS INLIN VLV SPHN/UNIT CAT; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL CERTAS INLIN VLV SPHN/UNIT CAT; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS Back to Search Results
Catalog Number 82-8806
Device Problem Fluid/Blood Leak (1250)
Patient Problem Cerebrospinal Fluid Leakage (1772)
Event Date 12/10/2018
Event Type  Injury  
Manufacturer Narrative
Udi -- (b)(4).Attempts are being made to obtain additional information.Upon receipt of new relevant information, a follow-up report will be submitted.
 
Event Description
As reported by the affiliate, after 11 days, a hakim valve was suspected of leaking and was revised.Initial setting were unknown.However, cerebrospinal fluid was confirmed to be collected around the implanted valve near the iliac bone.It was suspected that cerebrospinal fluid could be leaking, therefore, a revision surgery was performed.The product will be returned.There was no confirmation of pin holes or leakage from connection parts.
 
Manufacturer Narrative
Additional information: pma/510k, if follow-up, what type, device evaluated by mfr.The device was returned for evaluation.The valve was visually inspected; needle guard was slightly raised.The valve was tested for programming and passed.The valve was flushed; no occlusion was noted.The valve was leak tested; no leaks noted.The valve was reflux tested and passed.The siphon guard was teste; no issues found.The siphon guard was removed.The valve was then pressure tested and passed.A review of manufacturing records could not be performed, as no lot number was provided.Based on the results of the investigation, the reported issue could not be confirmed, the device functioned as intended.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
 
Manufacturer Narrative
Udi: (b)(4).Additional information was received from the affiliate regarding the device involved in the reported event.This report has been updated with the corrected information.The device has been returned for evaluation.Upon completion of the investigation, a follow-up report will be submitted.
 
Event Description
As reported by the affiliate, after 11 days, a certas plus valve was suspected of leaking and was revised.Initial setting were unknown.However cerebrospinal fluid was confirmed to be collected around the implanted valve near the iliac bone.It was suspected that cerebrospinal fluid could be leaking, therefore, a revision surgery was performed.The product will be returned.There was no confirmation of pin holes or leakage from connection parts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CERTAS INLIN VLV SPHN/UNIT CAT
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM & COMPS
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
rue girardet 29
le locle MA CH 24 00
SZ  CH 2400
MDR Report Key8190387
MDR Text Key131183022
Report Number1226348-2018-10909
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K152152
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 12/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number82-8806
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/04/2019
Date Manufacturer Received02/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-